Ep 38 - HIMS WEEK IN REVIEW: Bloomberg, WaPo, Canada, Blood Tests, Nighthawk, and 38% Short Interest 🤯
Hims House
00:00
Navigating Financial Insights in Healthcare
This chapter explores the financial performance of HIMSS in relation to alternative data, particularly focusing on the influence of GLP-1 medications on revenue growth. It highlights discrepancies in data interpretation, market competition, and the implications of changing regulations on advertising strategies. Overall, the discussion emphasizes the need for ongoing market analysis and adaptability in order to sustain growth amidst evolving industry dynamics.
Transcript
Play full episode
